Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
Clinical trial NCT00387894 · TERMINATED
Trial details
- NCT number
- NCT00387894
- Sponsor
- Michael Prados
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-01-01
- Primary completion
- 2009-03-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.